X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs PIRAMAL ENTERPRISES - Comparison Results

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE PIRAMAL ENTERPRISES TTK HEALTHCARE/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 18.0 8.3 215.8% View Chart
P/BV x 5.9 1.5 392.1% View Chart
Dividend Yield % 0.5 1.1 45.4%  

Financials

 TTK HEALTHCARE   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
PIRAMAL ENTERPRISES
Mar-18
TTK HEALTHCARE/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs6633,083 21.5%   
Low Rs3991,902 21.0%   
Sales per share (Unadj.) Rs535.6589.7 90.8%  
Earnings per share (Unadj.) Rs15.9284.0 5.6%  
Cash flow per share (Unadj.) Rs20.0310.5 6.4%  
Dividends per share (Unadj.) Rs4.0025.00 16.0%  
Dividend yield (eoy) %0.81.0 75.1%  
Book value per share (Unadj.) Rs137.61,467.0 9.4%  
Shares outstanding (eoy) m7.77180.27 4.3%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x1.04.2 23.5%   
Avg P/E ratio x33.38.8 379.6%  
P/CF ratio (eoy) x26.58.0 330.4%  
Price / Book Value ratio x3.91.7 227.2%  
Dividend payout %25.18.8 285.0%   
Avg Mkt Cap Rs m4,127449,332 0.9%   
No. of employees `0001.76.8 25.0%   
Total wages/salary Rs m60719,881 3.1%   
Avg. sales/employee Rs Th2,436.715,535.6 15.7%   
Avg. wages/employee Rs Th355.22,905.4 12.2%   
Avg. net profit/employee Rs Th72.57,482.5 1.0%   
INCOME DATA
Net Sales Rs m4,162106,310 3.9%  
Other income Rs m612,595 2.4%   
Total revenues Rs m4,223108,906 3.9%   
Gross profit Rs m19751,599 0.4%  
Depreciation Rs m324,773 0.7%   
Interest Rs m3029,783 0.1%   
Profit before tax Rs m19719,638 1.0%   
Minority Interest Rs m02,801 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m73-28,764 -0.3%   
Profit after tax Rs m12451,203 0.2%  
Gross profit margin %4.748.5 9.8%  
Effective tax rate %37.0-146.5 -25.3%   
Net profit margin %3.048.2 6.2%  
BALANCE SHEET DATA
Current assets Rs m1,629118,154 1.4%   
Current liabilities Rs m1,058462,260 0.2%   
Net working cap to sales %13.7-323.7 -4.2%  
Current ratio x1.50.3 602.4%  
Inventory Days Days3027 112.0%  
Debtors Days Days3447 72.2%  
Net fixed assets Rs m556113,727 0.5%   
Share capital Rs m78361 21.6%   
"Free" reserves Rs m878264,093 0.3%   
Net worth Rs m1,069264,454 0.4%   
Long term debt Rs m159242,206 0.1%   
Total assets Rs m2,399726,834 0.3%  
Interest coverage x7.61.7 456.7%   
Debt to equity ratio x0.10.9 16.2%  
Sales to assets ratio x1.70.1 1,185.9%   
Return on assets %6.411.1 57.5%  
Return on equity %11.619.4 59.8%  
Return on capital %18.510.3 179.0%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m3315,110 0.2%   
Fx outflow Rs m634,298 1.5%   
Net fx Rs m-3010,813 -0.3%   
CASH FLOW
From Operations Rs m127-159,666 -0.1%  
From Investments Rs m-146-17,677 0.8%  
From Financial Activity Rs m22186,503 0.0%  
Net Cashflow Rs m39,364 0.0%  

Share Holding

Indian Promoters % 65.4 52.9 123.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 4.0 92.5%  
FIIs % 5.2 26.6 19.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 16.5 156.4%  
Shareholders   12,723 93,274 13.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ALEMBIC LTD  SUN PHARMA  PFIZER  GLENMARK PHARMA  SHASUN PHARMA  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Finish Flat; IT and Pharma Stocks Witness Selling(Closing)

Share markets in India ended their trading session on a flattish note. Sectoral indices ended on a mixed note with stocks in the IT sector and pharma sector witnessing most of the selling pressure.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 15.3% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, TTK HEALTHCARE has posted a net profit of Rs 67 m (down 15.3% YoY). Sales on the other hand came in at Rs 2 bn (up 16.3% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY19); Net Profit Up 59.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 59.3% YoY). Sales on the other hand came in at Rs 31 bn (up 24.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Get this Small Cap Logistics Company at a 16% Discount Right Now...(Profit Hunter)

Nov 6, 2018

If you turn the clock back, the current macroeconomic climate is nothing new. The markets have seen them all, and every downcycle has been succeeded by gravity defying gains...more so in the small cap space. This time will be no different.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Nov 14, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS